BusinessSummit Therapeutics to Present at 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 6, 2016, 11:00 AM UTC
BusinessSummit Announces Publication on Biomarkers to Quantify Utrophin Protein and Regeneration of Muscle Fibres in DMDBy Nasdaq OMXMar 15, 2016, 11:00 AM UTC
BusinessSummit Therapeutics Supports Ninth Annual Rare Disease DayBy Nasdaq OMXFeb 29, 2016, 12:35 PM UTC
BusinessSummit Therapeutics Receives Regulatory Approval to Initiate PhaseOut DMD, a Phase 2 Clinical Trial of SMT C1100 in Patients With DMDBy Nasdaq OMXJan 21, 2016, 12:00 PM UTC
